愛汝清注射液５００毫克

מדינה: טייוואן

שפה: סינית

מקור: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

מרכיב פעיל:

METRONIDAZOLE

זמין מ:

賽諾菲股份有限公司 台北市信義區松仁路3號7樓 (97168356)

קוד ATC:

J01XD01

טופס פרצבטיות:

注射劑

הרכב:

METRONIDAZOLE (0832000300) 500MG

יחידות באריזה:

瓶裝;;塑膠軟袋裝

סיווג:

製　劑

סוג מרשם:

限由醫師使用

תוצרת:

BAXTER HEALTHCARE S.A. MONEEN ROAD CASTLEBAR CO. MAYO, IRELAND IE

איזור תרפויטי:

metronidazole

סממני תרפויטית:

對ＭＥＴＲＯＮＩＤＡＺＯＬＥ具有感受性之厭氧菌所引起之嚴重感染及對ＣＬＩＮＤＡＭＹＣＩＮ　ＣＨＬＯＲＡＭＰＨＥＮＩＣＯＬ　ＰＥＮＩＣＩＬＬＩＮ具抗藥性之易脆桿菌（ＢＡＣＴＥＲＩＯＤＥＳ　ＦＬＡＧＩＬＩＳ）所引起之感染有效

leaflet_short:

註銷日期: 2019/04/12; 註銷理由: 自請註銷; 有效日期: 2019/09/16; 英文品名: ANEGYN INJECTION 0.5%W/V

מצב אישור:

已註銷

תאריך אישור:

1985-09-16

עלון מידע

1/6
ANEGYN®
_Metronidazole _
0,5%
W/V (100 ml)
ANEGYN INJECTION 0.5% W/V
1.
DESCRIPTION
1.1 ACTIVE INGREDIENT
Metronidazole
1.2 PHARMACEUTICAL FORM
A clean, bright, pale yellow sterile isotonic solution for intravenous
infusion.
1.3 COMPOSITION
Active ingredient: Metronidazole
Excipients: Sodium phosphate, Citric acid anhydrous, Sodium chloride,
Water for injections.
1.4
NATURE AND CONTENTS OF CONTAINER
Anegyn Injection 0.5% w/v (100 ml) is available in Viaflex minibags.
2. INDICATIONS
Anegyn is indicated in the prophylaxis and treatment of infections in
which anaerobic bacteria have been
identified or are suspected to be the cause.
Anegyn is active against a wide range of pathogenic microorganisms
notably species of
_Bacteroides, _
_Fusobacteria, Clostridia, Eubacteria, _
anaerobic cocci and
_Gardnerella vaginalis. _
It is indicated in:
The prevention of postoperative infections due to anaerobic bacteria,
particularly species of
_Bacteroides _
and
anaerobic Streptococci.
The treatment of septicaemia, bacteraemia, peritonitis, brain abscess,
necrotising pneumonia, osteomyelitis,
puerperal sepsis, pelvic abscess, pelvic cellulitis, and
postoperative wound infections from which pathogenic anaerobes have
been isolated.
3. DOSAGE AND ADMINISTRATION
Slow intravenous infusion of one 100 ml plastic bag (500 mg) over a
period of 30
to 60 minutes. Oral medication should be substituted as soon as
feasible.
_ANAEROBIC INFECTIONS: _
Treatment for seven days should be satisfactory for most
patients but, depending upon clinical and bacteriological assessments,
the physician
might decide to prolong treatment e.g. for the eradication of
infection from sites
which cannot be drained or are liable to endogenous recontamination by
anaerobic
pathogens from the gut, oropharynx or genital tract.
_PROPHYLAXIS AGAINST ANAEROBIC INFECTION: _
Adults
Usually, 500mg infused over 30 to 60 minutes immediately before
surgery, followed by 2 infusions of 500mg
at 8 hours and 16 hours after the initial dose.
Children
2/6
20 to 30 mg/kg per day us